Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Superstar Cher Escalates Feud With Nanthealth's Soon-Shiong January 9, 2018 Booming Celltrion Falls After FDA Warning Letter January 31, 2018 Atlas Genetics Taps Life Sciences Vet as New CEO October 2, 2017
